Monthly Archives: December 2017

13 December 2017

Microsaic Systems – signs new phase of research agreement with a global partner in biopharma

By |December 13th, 2017|

Microsaic Systems plc
(“Microsaic” or the “Company”)
Microsaic signs new phase of research agreement with a global partner in biopharma
Microsaic Systems plc (AIM: MSYS), the developer of chip-based mass spectrometry instruments, announces that it has signed a research agreement extending its collaboration with a long standing global partner in the scale up and manufacture of biopharmaceutical […]

Xeros: Proposed £25m Placing

By |December 12th, 2017|

Xeros Technology Group plc
Proposed Placing to raise approximately £25 million
Xeros Technology Group plc (AIM: XSG, ‘the Group’, ‘Xeros’), the developer and provider of patented polymer based technologies with multiple commercial applications, intends to raise approximately £25 million before fees and expenses by a Placing of 11,111,112 new ordinary shares with existing and new institutional investors […]

Parkwalk closes Mirriad investment

By |December 8th, 2017|

We are pleased to announce that Parkwalk has participated in the successful Mirriad IPO. The company raised £26.2m on its admission to AIM.
Mirriad is the leading provider of NIVA (Native In-Video Advertising) services to brands and agencies looking to address the growing challenges presented by ‘ad skipping’ and ‘ad blindness’. The Mirriad technology was originally […]

Portfolio company Mirriad announces £26.2m fundraising and proposed admission to AIM

By |December 8th, 2017|

Parkwalk is pleased to note that portfolio company Mirriad Advertising plc (“Mirriad”), the global video technology company and developer of native in-video advertising, has successfully priced its Initial Public Offering and has applied for the admission of its entire issued and to be issued share capital to AIM.

Mirriad has announced the raising of £26.2 […]